Advertisement

Topics

New York Times vs. Personalized Medicine? PMC President: Times’ Critique of Streamlined Regulatory Approval for Personalized Treatments ‘Ignores Promising Implications’ of Field


Contact: Christopher J. Wells Personalized Medicine Coalition cwells@personalizedmedicinecoalition.org 202-589-1770 FOR IMMEDIATE RELEASE   New York Times vs. Personalized Medicine? PMC President: Times’ Critique of Streamlined Regulatory Approval for Personalized Treatments ‘Ignores Promising Implications’ of Field WASHINGTON (June 13, 2018) — In response to an editorial published on June 9 by the New York Times titled […]

Original Article: New York Times vs. Personalized Medicine? PMC President: Times’ Critique of Streamlined Regulatory Approval for Personalized Treatments ‘Ignores Promising Implications’ of Field

NEXT ARTICLE

More From BioPortfolio on "New York Times vs. Personalized Medicine? PMC President: Times’ Critique of Streamlined Regulatory Approval for Personalized Treatments ‘Ignores Promising Implications’ of Field"

Advertisement
Quick Search
Advertisement
Advertisement